141 related articles for article (PubMed ID: 7528568)
1. Induction of differentiation of WEHI-3B D+ leukemic cells transfected with differentiation-stimulating factor/leukemia inhibitory factor receptor cDNA.
Tomida M
Blood; 1995 Jan; 85(1):217-21. PubMed ID: 7528568
[TBL] [Abstract][Full Text] [Related]
2. Oncostatin M is a differentiation factor for myeloid leukemia cells.
Bruce AG; Hoggatt IH; Rose TM
J Immunol; 1992 Aug; 149(4):1271-5. PubMed ID: 1380037
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic domains of the leukemia inhibitory factor receptor required for STAT3 activation, differentiation, and growth arrest of myeloid leukemic cells.
Tomida M; Heike T; Yokota T
Blood; 1999 Mar; 93(6):1934-41. PubMed ID: 10068666
[TBL] [Abstract][Full Text] [Related]
4. The box-1 region of the leukemia inhibitory factor receptor alpha-chain cytoplasmic domain is sufficient for hemopoietic cell proliferation and differentiation.
Zhang Y; Willson T; Metcalf D; Cary D; Hilton DJ; Clark R; Nicola NA
J Biol Chem; 1998 Dec; 273(51):34370-83. PubMed ID: 9852103
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of macrophage differentiation in response to leukemia inhibitory factor/oncostatin-M/interleukin-6: the effect of enforced expression of the SCL transcription factor.
Tanigawa T; Nicola N; McArthur GA; Strasser A; Begley CG
Blood; 1995 Jan; 85(2):379-90. PubMed ID: 7811994
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the differentiation of WEHI-3B D+ leukemia cells by granulocyte colony-stimulating factor receptor.
Li J; Koay DC; Xiao H; Sartorelli AC
J Cell Biol; 1993 Mar; 120(6):1481-9. PubMed ID: 7680656
[TBL] [Abstract][Full Text] [Related]
7. Clonal analysis of the actions of the murine leukemia inhibitory factor on leukemic and normal murine hemopoietic cells.
Metcalf D; Hilton DJ; Nicola NA
Leukemia; 1988 Apr; 2(4):216-21. PubMed ID: 2452326
[TBL] [Abstract][Full Text] [Related]
8. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
[TBL] [Abstract][Full Text] [Related]
9. Structural and functional studies on the leukemia inhibitory factor receptor (LIF-R): gene and soluble form of LIF-R, and cytoplasmic domain of LIF-R required for differentiation and growth arrest of myeloid leukemic cells.
Tomida M
Leuk Lymphoma; 2000 May; 37(5-6):517-25. PubMed ID: 11042511
[TBL] [Abstract][Full Text] [Related]
10. Oncostatin M (OSM) inhibits the differentiation of pluripotent embryonic stem cells in vitro.
Rose TM; Weiford DM; Gunderson NL; Bruce AG
Cytokine; 1994 Jan; 6(1):48-54. PubMed ID: 8003633
[TBL] [Abstract][Full Text] [Related]
11. The SCL gene product is regulated by and differentially regulates cytokine responses during myeloid leukemic cell differentiation.
Tanigawa T; Elwood N; Metcalf D; Cary D; DeLuca E; Nicola NA; Begley CG
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7864-8. PubMed ID: 8356096
[TBL] [Abstract][Full Text] [Related]
12. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
[TBL] [Abstract][Full Text] [Related]
13. An antagonist for the leukemia inhibitory factor receptor inhibits leukemia inhibitory factor, cardiotrophin-1, ciliary neurotrophic factor, and oncostatin M.
Vernallis AB; Hudson KR; Heath JK
J Biol Chem; 1997 Oct; 272(43):26947-52. PubMed ID: 9341130
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein.
Chevalier S; Fourcin M; Robledo O; Wijdenes J; Pouplard-Barthelaix A; Gascan H
J Biol Chem; 1996 Jun; 271(25):14764-72. PubMed ID: 8662918
[TBL] [Abstract][Full Text] [Related]
15. Analysis of recombinant soluble mouse D-factor/LIF receptor.
Tomida M
J Biochem; 1995 Jun; 117(6):1228-31. PubMed ID: 7490264
[TBL] [Abstract][Full Text] [Related]
16. Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor.
Plun-Favreau H; Perret D; Diveu C; Froger J; Chevalier S; Lelièvre E; Gascan H; Chabbert M
J Biol Chem; 2003 Jul; 278(29):27169-79. PubMed ID: 12707269
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of interleukin 6 receptors of mouse myelomonocytic leukemic cells by leukemia inhibitory factor.
Yamaguchi M; Michishita M; Hirayoshi K; Yasukawa K; Okuma M; Nagata K
J Biol Chem; 1992 Nov; 267(31):22035-42. PubMed ID: 1429553
[TBL] [Abstract][Full Text] [Related]
18. [Function, molecular structure and gene expression regulation of receptor for D-factor/LIF].
Tomida M
Nihon Rinsho; 1992 Aug; 50(8):1956-61. PubMed ID: 1433987
[TBL] [Abstract][Full Text] [Related]
19. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor.
Gearing DP; Comeau MR; Friend DJ; Gimpel SD; Thut CJ; McGourty J; Brasher KK; King JA; Gillis S; Mosley B
Science; 1992 Mar; 255(5050):1434-7. PubMed ID: 1542794
[TBL] [Abstract][Full Text] [Related]
20. Autoinduction of differentiation in WEHI-3B leukemia cells.
Metcalf D; Nicola NA
Int J Cancer; 1982 Dec; 30(6):773-80. PubMed ID: 6984432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
